Table 2.
Demographical and clinical characteristics of 101 diabetic foot patients with necrotizing fasciitis
| Variables | Number (%) |
|---|---|
| Male | 67 (66.3%) |
| Female | 34 (33.7%) |
| Age | 60.32 ± 11.62 |
| Type 1 Diabetes | 3 (3.0%) |
| Type 2 Diabetes | 98 (97.0%) |
| The duration of diabetes, years | 10.27 ± 7.09 |
| Blood Glucose (mmol/l) | 16.37 ± 6.29 |
|
HbA1c (%) ≤ 7% (good control) |
11.46 ± 2.79 6 (5.8%) |
| Hospital stays, days | 30.17 ± 21.93 |
| Duration of the ulcer, days | |
| 30 days or less | 76 (75.2%) |
| Over 30 days | 25 (24.8%) |
| The type of insulin | |
| Pre-mixed insulins | 22 (21.8%) |
| Intermediate-acting insulin (NPH) | 7 (6.9%) |
| Rapidly acting insulin analogs + Basal insulin analogs | 5 (5.0%) |
| Rapidly acting insulin analogs | 3 (3.0%) |
| Basal insulin analogs | 2 (2.0%) |
| Rapidly acting insulin analogs + NPH | 1 (1.0%) |
| Type of insulin was not known | 4 (4.0%) |
| Location of foot ulcers | |
| Planta | 31 |
| Foot dorsum | 20 |
| Hallux | 17 |
| The second phalanx | 14 |
| The third phalanx | 10 |
| The fourth phalanx | 9 |
| The fifth phalanx | 26 |
| Others | 19 |
| Concomitant disease | |
| Hypertension | 46 (45.5%) |
| Anemia | 26 (25.7%) |
| Hypoproteinemia | 25 (24.8%) |
| Osteoporosis | 20 (19.8%) |
| Lower extremity atherosclerotic occlusive disease | 18 (17.8%) |
| Complications | |
| Neuropathy | 95 (94.1%) |
| Lower extremity vascular disease | 49 (48.5%) |
| Nephropathy | 43 (42.6%) |
| Retinopathy | 54 (53.5%) |
| The amputation rate | 32 (31.7%) |
| Antibiotics use before admission | 73 (72.3%) |